Welcome to our dedicated page for Ekso Bionics news (Ticker: EKSO), a resource for investors and traders seeking the latest updates and insights on Ekso Bionics stock.
Ekso Bionics (EKSO) pioneers wearable robotic exoskeletons that redefine human mobility in healthcare and industrial settings. This page aggregates all official company announcements, financial updates, and milestone developments for stakeholders tracking innovation in assistive technology and industrial robotics.
Access curated press releases covering product launches, strategic partnerships, regulatory milestones, and financial performance. Our repository ensures investors and industry observers stay informed about advancements in exoskeleton technology and their real-world applications.
Discover updates on EksoHealth’s medical breakthroughs supporting rehabilitation and EksoWorks’ industrial solutions enhancing workplace safety. Each entry provides factual summaries of developments impacting the wearable robotics sector.
Bookmark this page for streamlined access to EKSO’s evolving narrative. Check regularly for authoritative insights into one of robotics’ most dynamic innovators.
Ekso Bionics Holdings (Nasdaq: EKSO) will announce its financial and business results for Q1 2023 on April 27, 2023. The release will take place after the close of trading, followed by a conference call at 1:30 PM PT / 4:30 PM ET to discuss the results and recent developments. A live webcast will be available on the Company’s website, providing investors with real-time insights. This call presents an opportunity for stakeholders to engage with management regarding the company’s performance in the exoskeleton technology sector, which serves both medical and industrial markets. The replay of the call will also be accessible for one month post-event.